Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $999K 23.5K sh |
| Oct 5, 2026 traded Oct 2, 2026 |
| 8 | McGrane AshleyGeneral Counsel and Corp Sec | Open-market sale · 10b5-1 plan | SELL | $9,239 2,461 sh | Oct 5, 2026 traded Oct 2, 2026 |
| 7 | Denier Anthony MichaelDirector, President | Open-market sale · 10b5-1 plan | SELL | $395K 53.8K sh | Oct 5, 2026 traded Oct 5, 2026 |
| 6 | Robinson Mark HaymondGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $99K 3,882 sh | Oct 5, 2026 traded Oct 5, 2026 |
| 6 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $108K 2,596 sh | Oct 5, 2026 traded Oct 2, 2026 |
| 60 | Mindlin Damian MiguelVicepresident | Open-market purchase | BUY | $4.40M 1.42M sh | Oct 2, 2026 traded Sep 28, 2026 |
| 56 | Mindlin Damian MiguelVicepresident | Open-market purchase | BUY | $1.16M 15.0K sh | Oct 2, 2026 traded Sep 28, 2026 |
| 47 | Garcia Cuellar Maria ReginaDirector | Open-market purchase | BUY | $8,274 403 sh | Oct 2, 2026 traded Sep 29, 2026 |
| 40 | Nancy PelosiDSpouse | REOF XXX, LLC Purchase | BUY | $500K – $1.00M | Oct 2, 2026 traded Sep 8, 2026 |
| 36 | Michael A. RulliRSelf | Partial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 28, 2026 |
| 35 | Lin Yi-Chien10% Owner | Open-market purchase | BUY | $8,070 3,000 sh | Oct 2, 2026 traded Sep 29, 2026 |
| 33 | Garcia Cuellar Maria ReginaDirector | Open-market purchase | BUY | $8,672 423 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 33 | Nechmad YairCEO, Co Founder & Chairman | Open-market purchase | BUY | $777K 16.2K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 33 | Nechmad YairCEO, Co Founder & Chairman | Open-market purchase | BUY | $889K 18.3K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 33 | Nechmad YairCEO, Co Founder & Chairman | Open-market purchase | BUY | $446K 9,616 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 32 | Kleinerman ChristianEVP, Product Management | Open-market sale · 10b5-1 plan | SELL | $5.12M 15.0K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 30 | Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks | Open-market sale | SELL | $2.76M 556.0K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 29 | Michael A. RulliRSelf | Purchase | BUY | $1,001 – $15K | Oct 2, 2026 traded Sep 3, 2026 |
| 29 | Lin Yi-Chien10% Owner | Open-market purchase | BUY | $43K 15.4K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 27 | Colendich Katie MarieGC, Corporate Secretary | Open-market sale | SELL | $55K 6,318 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 25 | Lin Yi-Chien10% Owner | Open-market purchase | BUY | $5,420 2,000 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 21 | Lee Chan HenrySVP, General Counsel | Open-market sale · 10b5-1 plan | SELL | $418K 1,115 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 21 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $435K 16.1K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 21 | Spice Adam C.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $6.05M 85.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 20 | Michael A. RulliRSelf | Partial sale | SELL | $1,001 – $15K | Oct 2, 2026 traded Sep 3, 2026 |
| 18 | Serafini John SheldonDirector, President and CEO | Open-market sale · 10b5-1 plan | SELL | $1.36M 92.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1.09M 15.2K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $2.79M 39.7K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 16 | Gimbel LisaCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $9,495 500 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.64M 17.0K sh | Oct 2, 2026 traded Oct 2, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.66M 17.0K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $766K 1,846 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $394K 954 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $446K 3,882 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $82K 200 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Raghavan VaidyanathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $56K 549 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 6 | Abdelsadek MohamedEVP, Chief Global Solutions | Open-market sale · 10b5-1 plan | SELL | $16K 250 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Schubach Sarah ElizabethChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $66K 2,025 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 4 | Johnston James DavidExecutive VP, GC, CCO and Secy | Open-market sale · 10b5-1 plan | SELL | $79K 2,600 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $3,401 32 sh | Oct 2, 2026 traded Oct 2, 2026 |